LINE 5 – new organizational models: pdta (diagnostic and therapeutic care pathways) and indicators
The main objective in the drafting of the Oncology Network’s PDTA (DGR 2067/2013) is to ensure promptness, adequate levels and continuity of care throughout the care pathway: from the moment the patient enters the pathway, to the multidisciplinary evaluation of his or her tumor, until complete remission or end of life.
The preservation of a respectable quality of life, from the early stages onward, the provision of adequate support for the patient and his or her family, and the protection of the dignity and autonomy of cancer patients are an integral part of the PDTA.
The IOV is the hub of the hospital and territorial oncology network of the Veneto Region (ROV). It coordinates regional oncology care in close harmony with all hospital companies of the Veneto region. PDTA for various types of cancers have been defined and shared among the hospitals.
In the context of demand management, an organizational model that puts the cancer patient at the center and is able to respond to ethical and social needs is necessary to reduce drop-out from the defined care pathways.
Monitoring of the PDTA through specific performance indicators makes it possible to analyze cancer care across the network. It becomes, therefore, of strategic importance to identify indicators of performance within the Institute that can also be expanded to the regional level. This will make it possible to have quantitative evidence for business and healthcare planning of the Institute in order to verify the appropriateness, continuity and uniformity of care, and the quality of the services offered.
Analysis of performance indicators will allow on-site verification of improvements introduced by the PDTAs and will help guide decisions. Indicators are today identified with information obtained from the current information flows (specialist care, hospitalization, pharmaceutical, home care, regional mortality register), appropriately integrated with record linkage techniques.
The overall goal of this research line is to evaluate the compliance to ROV PDTA indicators in patients treated at the Veneto Institute of Oncology in the various care pathways. In particular:
- monitoring of adherence to performance indicators;
- implementation of internal audits;
- analysis of any corrective systems.
- The development of an application that will provide direct access to structure and process indicator data that can be extracted from regional information flows to verify the true state of cancer patient care as defined by the various PDTAs of the Veneto Oncology Network.
- Measurable activities used as indicators to verify results:
- number of admissions for surgery;
- waiting times to begin chemotherapy / post-intervention radiotherapy;
- chemotherapy in the last 30 days of life;
- inappropriate diagnostic tests (TAC, Magnetic Resonance, PET, etc);
- number of audits developed.
|Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)||Imbimbo M., Ottaviano M., Vitali M., Fabbri A., Leuzzi G., Fiore M., Franceschini D., Pasello Giulia, Perrino M., Schiavon M., Pruneri G., Dei Tos A.P., Sangalli C., Garassino M.C., Berardi R., Alessi A., Calareso G., Petrini I., Scorsetti M., Scotti V., Rosso L., Rea F., Pastorino U., Casali P.G., Ramella S., Ricardi U., Abate-Daga L., Torri V., Trama A., Palmieri G., Marino M., Zucali P.A., collaborators TYME network||CANCER TREATMENT REVIEWS||8.122|
|A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2)||Tagliafico Alberto S, Mariscotti Giovanna, Valdora Francesca, Durando Manuela, Nori Jacopo, La Forgia Daniele, Rosenberg Ilan, Caumo Francesca, Gandolfo Nicoletta, Sormani Maria Pia, Signori Alessio, Calabrese Massimo, Houssami Nehmat||EUROPEAN JOURNAL OF CANCER||7.191|
|Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial||Investigators ICOS-ONE Study, Cardinale Daniela, Ciceri Fabio, Latini Roberto, Franzosi Maria Grazia, Sandri Maria Teresa, Civelli Maurizio, Cucchi Gian Franco, Menatti Elisabetta, Mangiavacchi Maurizio, Cavina Raffaele, Barbieri Enrico, Gori Stefania, Colombo Alessandro, Curigliano Giuseppe, Salvatici Michela, Rizzo Antonio, Ghisoni Francesco, Bianchi Alessandra, FALCI CRISTINA, Aquilina Michele, Rocca Andrea, Monopoli Anna, Milandri Carlo, Rossetti Giuseppe, Bregni Marco, Sicuro Marco, Malossi Alessandra, Nassiacos Daniele, Verusio Claudio, Giordano Monica, Staszewsky Lidia, Barlera Simona, Masson Serge, Cipolla Carlo M., Maggioni A. P., Tettamanti M., Pellegrini C., Scognamiglio G., Corrado G., De Rosa F., Callegari S., Fodor C., Mazza R., Sala E., Fragasso G., Farolfi A., Andreis D., Gervasi E., Barco B.||EUROPEAN JOURNAL OF CANCER||7.191|
|First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer||Dieci Maria Vittoria, Guarneri Valentina, Giarratano Tommaso, Mion M., Tortora G., De Rossi C., Gori Stefania, Oliani C., Merlini L., Pasini F., Bonciarelli G., Griguolo G., Orvieto E., michieletto silvia, saibene tania, Del Bianco Paola, De Salvo Gian Luca, Conte Pierfranco||ONCOLOGIST||5.306|
|Changes in food habits in cancer patients in Italy: a survey. AIOM - SINPE - FAVO||group AIOM-SINPE-FAVO working, Gavazzi Cecilia, Sieri Sabina, Tracl¿¿ Francesca, Sproviero Alessandro, Vandoni Giulia, Ricci Roberta, Stragliotto Silvia, zagonel vittorina||NUTRITION||3.734|
|Quality assurance and sustainability of cancer care A European networkÂ is needed||Rossi Carlo Riccardo, Sommariva Antonio, Bastiaannet Esther, Van De Velde Cornelis J H||EJSO||3.688|
|Quality assurance in melanoma care The EU-MELACARE study||Sommariva Antonio, Forsea Ana-Maria, Agius Domenic, Ascierto Paolo Antonio, Bastiaannet Esther, Borgognoni Lorenzo, Demetriou Anna, Garbe Claus, Gavric Zivana, Hocevar Marko, Innos Kaire, Lar¿¿nningen Siri, Louwman Marieke, Robsahm Trude Eid, Rutkwoski Piotr, van Akkooi Alexander, Zorzi Manuel, Pasquali Sandro, van de Velde Cornelis, Rossi Carlo Riccardo||EJSO||3.688|
|Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening||Caumo Francesca, Romanucci Giovanna, Hunter Kylie, Zorzi Manuel, Brunelli Silvia, Macaskill Petra, Houssami Nehmat||BREAST CANCER RESEARCH AND TREATMENT||3.605|
|Social relationship coping efficacy A new construct in understanding social support and close personal relationships in persons with cancer||Merluzzi Thomas V, Serpentini Samantha, Philip Errol J, Yang Miao, Salamanca-Balen Natalia, Heitzmann Ruhf Carolyn A, Catarinella Antonio||PSYCHO-ONCOLOGY||3.455|
|Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide A Single-center Prospective Study||LOMBARDI GIUSEPPE, Bergo Eleonora, Del Bianco Paola, Bellu Luisa, Pambuku Ardi, Caccese Mario, Trentin Leonardo, zagonel vittorina||AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS||3.424|
|The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients||Battaglin Francesca, schirripa marta, Buggin Federica, Pietrantonio Filippo, Morano Federica, Boscolo Giorgia, Tonini Giuseppe, Lutrino Eufemia Stefania, Lucchetti Jessica, Salvatore Lisa, Passardi Alessandro, Cremolini Chiara, Arnoldi Ermenegildo, Scartozzi Mario, Pella Nicoletta, Boni Luca, Bergamo Francesca, zagonel vittorina, Loupakis Fotios, Lonardi Sara||BMC CANCER||3.288|
|Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines||Buja Alessandra, Sartor Gino, Scioni Manuela, Vecchiato Antonella, Bolzan Mario, Rebba Vincenzo, chiarion sileni vanna, Palozzo Angelo Claudio, montesco maria, Del Fiore Santo Paolo, Baldo Vincenzo, Rossi Carlo Riccardo||ACTA DERMATO-VENEREOLOGICA||3.127|
|An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts||Tagliafico Alberto Stefano, Valdora Francesca, Mariscotti Giovanna, Durando Maunela, Nori Jacopo, La Forgia Daniele, Rosenberg Ilan, Caumo Francesca, Gandolfo Nicoletta, Houssami Nehmat, Calabrese Massimo||BREAST||2.951|
|Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial||Houssami Nehmat, Bernardi Daniela, Caumo Francesca, Brunelli Silvia, Fant¿¿ Carmine, Valentini Marvi, Romanucci Giovanna, Gentilini Maria A, Zorzi Manuel, Macaskill Petra||BREAST||2.951|
|Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?||Montemezzi Stefania, Camera Lucia, Giri Maria Grazia, Pozzetto Alice, Cali¿¿ Anna, Meliad¿¿ Gabriele, Caumo Francesca, Cavedon Carlo||EUROPEAN JOURNAL OF RADIOLOGY||2.843|
Source: IOV Scientific library